WO1996011714A1 - Ciment osseux composite - Google Patents
Ciment osseux composite Download PDFInfo
- Publication number
- WO1996011714A1 WO1996011714A1 PCT/FR1995/001364 FR9501364W WO9611714A1 WO 1996011714 A1 WO1996011714 A1 WO 1996011714A1 FR 9501364 W FR9501364 W FR 9501364W WO 9611714 A1 WO9611714 A1 WO 9611714A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- cement
- cement according
- particles
- polymer particles
- mixture
- Prior art date
Links
- 239000002639 bone cement Substances 0.000 title claims abstract description 12
- 239000002131 composite material Substances 0.000 title claims abstract description 4
- 239000004568 cement Substances 0.000 claims abstract description 43
- 239000002245 particle Substances 0.000 claims abstract description 29
- 239000000203 mixture Substances 0.000 claims abstract description 24
- 229920000642 polymer Polymers 0.000 claims abstract description 18
- 239000012764 mineral filler Substances 0.000 claims abstract description 16
- 239000011230 binding agent Substances 0.000 claims abstract description 12
- 229920002988 biodegradable polymer Polymers 0.000 claims abstract description 7
- 239000004621 biodegradable polymer Substances 0.000 claims abstract description 7
- 239000011148 porous material Substances 0.000 claims abstract description 7
- 239000012530 fluid Substances 0.000 claims abstract description 5
- 230000035515 penetration Effects 0.000 claims abstract description 5
- 239000012766 organic filler Substances 0.000 claims abstract description 4
- 239000000843 powder Substances 0.000 claims description 15
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 14
- 229920001577 copolymer Polymers 0.000 claims description 13
- 239000000470 constituent Substances 0.000 claims description 12
- MYRTYDVEIRVNKP-UHFFFAOYSA-N 1,2-Divinylbenzene Chemical compound C=CC1=CC=CC=C1C=C MYRTYDVEIRVNKP-UHFFFAOYSA-N 0.000 claims description 10
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 claims description 10
- 238000002360 preparation method Methods 0.000 claims description 10
- 239000000463 material Substances 0.000 claims description 9
- 239000000178 monomer Substances 0.000 claims description 9
- 238000006116 polymerization reaction Methods 0.000 claims description 9
- 238000002156 mixing Methods 0.000 claims description 8
- 239000002952 polymeric resin Substances 0.000 claims description 8
- 229920003002 synthetic resin Polymers 0.000 claims description 8
- 235000014655 lactic acid Nutrition 0.000 claims description 7
- 239000004310 lactic acid Substances 0.000 claims description 7
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 6
- 239000011347 resin Substances 0.000 claims description 5
- 229920005989 resin Polymers 0.000 claims description 5
- BLRPTPMANUNPDV-UHFFFAOYSA-N Silane Chemical compound [SiH4] BLRPTPMANUNPDV-UHFFFAOYSA-N 0.000 claims description 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 4
- 239000003999 initiator Substances 0.000 claims description 4
- 229910000077 silane Inorganic materials 0.000 claims description 4
- RKDVKSZUMVYZHH-UHFFFAOYSA-N 1,4-dioxane-2,5-dione Chemical compound O=C1COC(=O)CO1 RKDVKSZUMVYZHH-UHFFFAOYSA-N 0.000 claims description 3
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 claims description 3
- AMFGWXWBFGVCKG-UHFFFAOYSA-N Panavia opaque Chemical compound C1=CC(OCC(O)COC(=O)C(=C)C)=CC=C1C(C)(C)C1=CC=C(OCC(O)COC(=O)C(C)=C)C=C1 AMFGWXWBFGVCKG-UHFFFAOYSA-N 0.000 claims description 3
- 239000002253 acid Substances 0.000 claims description 3
- 239000000945 filler Substances 0.000 claims description 3
- 239000011521 glass Substances 0.000 claims description 3
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 claims description 3
- XDLMVUHYZWKMMD-UHFFFAOYSA-N 3-trimethoxysilylpropyl 2-methylprop-2-enoate Chemical compound CO[Si](OC)(OC)CCCOC(=O)C(C)=C XDLMVUHYZWKMMD-UHFFFAOYSA-N 0.000 claims description 2
- JJTUDXZGHPGLLC-IMJSIDKUSA-N 4511-42-6 Chemical compound C[C@@H]1OC(=O)[C@H](C)OC1=O JJTUDXZGHPGLLC-IMJSIDKUSA-N 0.000 claims description 2
- 239000005995 Aluminium silicate Substances 0.000 claims description 2
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 2
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 claims description 2
- BPQQTUXANYXVAA-UHFFFAOYSA-N Orthosilicate Chemical compound [O-][Si]([O-])([O-])[O-] BPQQTUXANYXVAA-UHFFFAOYSA-N 0.000 claims description 2
- 229910000323 aluminium silicate Inorganic materials 0.000 claims description 2
- 235000012211 aluminium silicate Nutrition 0.000 claims description 2
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 2
- 229910052794 bromium Inorganic materials 0.000 claims description 2
- 238000012662 bulk polymerization Methods 0.000 claims description 2
- 239000000919 ceramic Substances 0.000 claims description 2
- 239000000460 chlorine Substances 0.000 claims description 2
- 229910052801 chlorine Inorganic materials 0.000 claims description 2
- 239000004927 clay Substances 0.000 claims description 2
- 150000001875 compounds Chemical class 0.000 claims description 2
- 125000003754 ethoxycarbonyl group Chemical group C(=O)(OCC)* 0.000 claims description 2
- 229910052736 halogen Inorganic materials 0.000 claims description 2
- 150000002367 halogens Chemical class 0.000 claims description 2
- -1 hydroxy carbonyl group Chemical group 0.000 claims description 2
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 claims description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 1
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 claims 1
- 229910052739 hydrogen Inorganic materials 0.000 claims 1
- 239000001257 hydrogen Substances 0.000 claims 1
- 239000011159 matrix material Substances 0.000 abstract description 3
- 239000012190 activator Substances 0.000 abstract 1
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 12
- 239000012071 phase Substances 0.000 description 11
- 239000011324 bead Substances 0.000 description 8
- 239000000243 solution Substances 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 229920000084 Gum arabic Polymers 0.000 description 6
- 239000000205 acacia gum Substances 0.000 description 6
- 235000010489 acacia gum Nutrition 0.000 description 6
- 244000215068 Acacia senegal Species 0.000 description 5
- 239000004342 Benzoyl peroxide Substances 0.000 description 5
- OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 description 5
- 235000019400 benzoyl peroxide Nutrition 0.000 description 5
- 210000000988 bone and bone Anatomy 0.000 description 5
- 239000012074 organic phase Substances 0.000 description 5
- 239000008346 aqueous phase Substances 0.000 description 4
- MOTZDAYCYVMXPC-UHFFFAOYSA-N dodecyl hydrogen sulfate Chemical compound CCCCCCCCCCCCOS(O)(=O)=O MOTZDAYCYVMXPC-UHFFFAOYSA-N 0.000 description 4
- 229940043264 dodecyl sulfate Drugs 0.000 description 4
- 239000003505 polymerization initiator Substances 0.000 description 4
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- JJTUDXZGHPGLLC-UHFFFAOYSA-N lactide Chemical compound CC1OC(=O)C(C)OC1=O JJTUDXZGHPGLLC-UHFFFAOYSA-N 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- DBCAQXHNJOFNGC-UHFFFAOYSA-N 4-bromo-1,1,1-trifluorobutane Chemical compound FC(F)(F)CCCBr DBCAQXHNJOFNGC-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 229920001222 biopolymer Polymers 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 238000007334 copolymerization reaction Methods 0.000 description 2
- 239000003431 cross linking reagent Substances 0.000 description 2
- 239000008367 deionised water Substances 0.000 description 2
- 229910021641 deionized water Inorganic materials 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- STVZJERGLQHEKB-UHFFFAOYSA-N ethylene glycol dimethacrylate Substances CC(=C)C(=O)OCCOC(=O)C(C)=C STVZJERGLQHEKB-UHFFFAOYSA-N 0.000 description 2
- 238000004898 kneading Methods 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000004820 osteoconduction Effects 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 239000004604 Blowing Agent Substances 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 239000007900 aqueous suspension Substances 0.000 description 1
- 229910052788 barium Inorganic materials 0.000 description 1
- DSAJWYNOEDNPEQ-UHFFFAOYSA-N barium atom Chemical compound [Ba] DSAJWYNOEDNPEQ-UHFFFAOYSA-N 0.000 description 1
- 230000002051 biphasic effect Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000000265 homogenisation Methods 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- 229920001480 hydrophilic copolymer Polymers 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 239000011325 microbead Substances 0.000 description 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
- 239000004926 polymethyl methacrylate Substances 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 239000010453 quartz Substances 0.000 description 1
- 239000007870 radical polymerization initiator Substances 0.000 description 1
- 238000007348 radical reaction Methods 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 239000003340 retarding agent Substances 0.000 description 1
- 238000007873 sieving Methods 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/0047—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
- A61L24/0073—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material with a macromolecular matrix
- A61L24/0094—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material with a macromolecular matrix containing macromolecular fillers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/001—Use of materials characterised by their function or physical properties
- A61L24/0036—Porous materials, e.g. foams or sponges
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/001—Use of materials characterised by their function or physical properties
- A61L24/0042—Materials resorbable by the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/02—Materials or treatment for tissue regeneration for reconstruction of bones; weight-bearing implants
Definitions
- the present invention relates to a new bone cement, useful as a composite filling material, hardenable by polymerization and gradually colonizable by bone.
- the bone cements known in the prior art generally comprise a polymer powder and a crosslinking agent intended to ensure the hardening of the cement, (EP-A-0 430 705, EP-A-0 361 408), optionally added of a mineral filler (EP-A-0 225 706, WO-A- 82/01990).
- These bone cements are generally prepared by mixing on the one hand a powder comprising the polymer and optionally the mineral filler, and on the other hand a liquid comprising monomers and polymerization initiators so as to react with the polymer powder, forming a resin which hardens on drying.
- Such cements are described in particular in application FR-A-
- the present invention therefore relates to a new bone cement consisting of:
- a biocompatible organic pulverulent filler (b) comprising the mixture, on the one hand of porous polymer particles ensuring the penetration of fluids in the cement (bl), and on the other hand of biodegradable polymer particles intended to leave pores of large diameter in the cement obtained to have osteoconduction (b2);
- the binding agent is used in the form of a liquid, mixed extemporaneously with a powder (pre-polymerized resinous powder particle) to form a paste.
- the current The invention therefore also relates to a pulverulent mixture consisting of the mineral filler (a) and the organic filler (b) defined above, useful for preparing the cement according to the invention, by subsequently mixing it with an appropriate binding agent, in the form preformed powder or paste.
- the biocompatible powdery mineral filler (a) consists of a material ensuring the mechanical strength of the cement and having good biocompatibility with regard to the medium in which the cement will be integrated.
- the pulverulent mineral filler (a) generally consists of a silicate material, natural or synthetic, in particular by powder of glass, ceramic, baked clay, as well as by powder of aluminosilicates, such as for example kaolin or with a phosphocalcic compound.
- the particles of mineral filler are substantially spherical and have an average diameter of less than 50 ⁇ m, advantageously between 5 and 20 ⁇ m, even more advantageously of approximately 10 ⁇ m.
- diameter is meant according to the invention the dimensions of the meshes of a sieve in which the particles flow by gravity.
- the particles of mineral filler will advantageously be silane, that is to say coated with a compatibilizing silane, for example methacryloxypropyl-trimethoxy-silane.
- the biocompatible organic pulverulent filler (b) consists of a mixture of two types of polymer particles, on the one hand porous polymer particles (b1) and on the other hand of biodegradable polymer particles (b2).
- the porous particles (bl) are intended to promote the penetration of fluids into the cement in order to promote the development of bone tissue, so that it gradually replaces the cement.
- the particles (b1) are essentially in the form of porous balls or spheres, the average diameter of which is greater than or equal to 500 ⁇ m and the average porosity is between 30 and 70% (measured with a mercury porosimeter). They consist of a biocompatible polymeric material, that is to say having harmless properties with respect to the medium in which the cement will be used, also chemically compatible with the other constituents of the cement. The polymeric material will also be biodegradable, that is to say absorbable by the organism in which the cement is used, the rate of resorption being however slow enough to allow the maintenance of the cement and of its cohesion during the development of the bone tissue. by penetration of physiological fluids through the pores.
- biocompatible biopolymers in particular crosslinked copolymers of glycol (meth) acrylate and of divinylbenzene.
- copolymers are advantageously obtained by emulsion copolymerization, a two-phase aqueous suspension consisting on the one hand of a mixture of glycol (meth) acrylate, of divinylbenzene and of toluene in respective weight proportions of between 8/1 / 10 and 4 / 1/6, preferably 6/1/8.
- the initiation of the copolymerization is carried out by a radical polymerization initiator soluble in the above organic phase but insoluble in water.
- the initiator is used in proportions of between 0J and 1% by weight.
- the second phase the aqueous biphasic phase also contains gum arabic, in particular acacia gum arabic (titrating from 0.5 to 1.5%) and a surfactant such as metal lauryl sulfate alkaline, especially sodium.
- gum arabic in particular acacia gum arabic (titrating from 0.5 to 1.5%)
- surfactant such as metal lauryl sulfate alkaline, especially sodium.
- the organic phase is divided into droplets which solidify by polymerization giving the macroporous beads.
- the biodegradable polymer particles (b2) are made up of a rapidly biodegradable polymeric material to give way to pores in the cement, unlike the material constituting the porous particles (b1) whose resorption must be slow and controlled.
- They are also essentially in the form of balls, or spheres, the average diameter of which is between 150 and 400 ⁇ m, so as to leave in the cement pores of the same diameter creating osteoconduction.
- the particles (b2) consist of usual biodegradable hydrophilic (co) polymers, in particular (co) polymers comprising units derived from (meth) acrylic acid and / or lactic acid and / or glycolic acid, or polyacryloid acid.
- R2 represents a hydroxy carbonyl group, a lower C 1 -C 4 alkoxy carbonyl group, for example ethoxy carbonyl, or a hydroxy group
- R3 represents a hydrogen atom or a hydroxy group, or alternatively
- the biodegradable polymer is a copolymer of lactic acid and glycolic acid comprising monomers L and D of lactic acid, in particular copolymers obtained by the polymerization of L-lactide , glycolid ci of D-lactide in a weight ratio close to 3: 4: 3, respectively.
- the binding agent (c) consists of a resin p ⁇ >l> ⁇ e. formed extemporaneously by mixing monomers and / or p. MIR ⁇ of low molecular weight and a polymerization initiator.
- This polymer resin must, of course, be chemically combined with the other constituents of the cement according to Riin Cmi ⁇ n. lk- must also have the characteristics of biocompatibility common to all of these constituents, taking into account their medical use.
- the polymer resin of the binding agent (c) is a bis-GMA resin.
- the polymer resin is obtained by polymerization of ethylene glycol dimethacrylate.
- the cement according to the invention is prepared by mixing and kneading the pulverulent mixture (a and b) according to the invention with a solution or a paste comprising the binding agent (c), in suitable proportions.
- the cement is obtained by mixing the pulverulent mixture with a powder consisting of monomers and / or polymers of low molecular weight, precursors of the polymer resin, then adding to the mixture obtained an aqueous solution comprising a polymerization initiator, such as benzoyl peroxide, and if necessary an agent delaying the polymerization.
- a polymerization initiator such as benzoyl peroxide
- the powdery mineral filler (a) represents between 60 and 80% by weight of the powdery mixture (a and b), preferably about 70% by weight.
- the weight ratio (b1) / (b2) between the two constituents of the pulverulent organic charge (b) is advantageously between 0.20 and 0.35.
- the weight ratio between the constituents of the pulverulent mixture (a and b) and the binding agent (c) is advantageously between 4 and 5.5.
- phase B 18% water.
- the GMA + divinylbenzene + toluene mixture with the reaction initiator (benzoyl peroxide) is carried out at the last moment, to avoid immediate polymerization.
- the mixture of phases A + B and the emulsion C are added to 200 ml of deionized water.
- the lauryl sulfate and gum arabic are removed by washing with ordinary water.
- the polymer which has been chosen is a copolymer of lactic acid and glycolic acid (PLa 30 Ga 40).
- the powder mixture consists of the following materials, per 100 g of powder:
- silane mineral fillers based on quartz, barium glass and silica, with a particle size of approximately 10 ⁇ m;
- biodegradable polymer beads (b2) obtained according to the protocol described in Example 2. The constituents are mixed by kneading.
- EXAMPLE 4 Preparation of a bone cement 100 g of the pulverulent mixture obtained above are added to 21.06 g of a pulverulent bis-GMA resinous organic matrix.
- an aqueous solution comprising a polymerization initiator, in particular benzoyl peroxide and an appropriate retarding agent so as to regulate the setting time of the cement according to the invention.
- a polymerization initiator in particular benzoyl peroxide
- an appropriate retarding agent so as to regulate the setting time of the cement according to the invention.
- the cement obtained may further comprise an appropriate dye.
- the physico-mechanical properties of the final product will be at least equal to those given by the ISO 5833 standard relating to bone cements based on PMMA.
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Materials Engineering (AREA)
- Surgery (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Composite Materials (AREA)
- Dispersion Chemistry (AREA)
- Materials For Medical Uses (AREA)
Abstract
Description
Claims
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP95935505A EP0797458A1 (fr) | 1994-10-17 | 1995-10-17 | Ciment osseux composite |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR94/12369 | 1994-10-17 | ||
FR9412369A FR2725625A1 (fr) | 1994-10-17 | 1994-10-17 | Ciment osseux composite |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1996011714A1 true WO1996011714A1 (fr) | 1996-04-25 |
Family
ID=9467927
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/FR1995/001364 WO1996011714A1 (fr) | 1994-10-17 | 1995-10-17 | Ciment osseux composite |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP0797458A1 (fr) |
FR (1) | FR2725625A1 (fr) |
WO (1) | WO1996011714A1 (fr) |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1058689C (zh) * | 1998-02-05 | 2000-11-22 | 华东理工大学 | 含有成孔剂的多孔磷酸钙骨水泥及其应用 |
US6689823B1 (en) | 1999-03-31 | 2004-02-10 | The Brigham And Women's Hospital, Inc. | Nanocomposite surgical materials and method of producing them |
WO2007007065A3 (fr) * | 2005-07-08 | 2007-06-07 | Depuy Int Ltd | Composition de ciment osseux |
US10729592B2 (en) | 2015-11-04 | 2020-08-04 | The Procter & Gamble Company | Absorbent structure |
US10729600B2 (en) | 2015-06-30 | 2020-08-04 | The Procter & Gamble Company | Absorbent structure |
US11020289B2 (en) | 2015-11-04 | 2021-06-01 | The Procter & Gamble Company | Absorbent structure |
US11173078B2 (en) | 2015-11-04 | 2021-11-16 | The Procter & Gamble Company | Absorbent structure |
US11266542B2 (en) | 2017-11-06 | 2022-03-08 | The Procter & Gamble Company | Absorbent article with conforming features |
US11376168B2 (en) | 2015-11-04 | 2022-07-05 | The Procter & Gamble Company | Absorbent article with absorbent structure having anisotropic rigidity |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2670114A1 (fr) * | 1990-12-10 | 1992-06-12 | Science Medecine | Materiau biocompatible et partiellement biodegradable, tel qu'un ciment pour scellement de prothese notamment orthopedique. |
-
1994
- 1994-10-17 FR FR9412369A patent/FR2725625A1/fr active Granted
-
1995
- 1995-10-17 EP EP95935505A patent/EP0797458A1/fr not_active Ceased
- 1995-10-17 WO PCT/FR1995/001364 patent/WO1996011714A1/fr not_active Application Discontinuation
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2670114A1 (fr) * | 1990-12-10 | 1992-06-12 | Science Medecine | Materiau biocompatible et partiellement biodegradable, tel qu'un ciment pour scellement de prothese notamment orthopedique. |
Cited By (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1058689C (zh) * | 1998-02-05 | 2000-11-22 | 华东理工大学 | 含有成孔剂的多孔磷酸钙骨水泥及其应用 |
US6689823B1 (en) | 1999-03-31 | 2004-02-10 | The Brigham And Women's Hospital, Inc. | Nanocomposite surgical materials and method of producing them |
US7279508B2 (en) | 1999-03-31 | 2007-10-09 | The Brigham And Women's Hospital, Inc. | Nanocomposite surgical materials and method of producing them |
WO2007007065A3 (fr) * | 2005-07-08 | 2007-06-07 | Depuy Int Ltd | Composition de ciment osseux |
US11957556B2 (en) | 2015-06-30 | 2024-04-16 | The Procter & Gamble Company | Absorbent structure |
US10729600B2 (en) | 2015-06-30 | 2020-08-04 | The Procter & Gamble Company | Absorbent structure |
US11020289B2 (en) | 2015-11-04 | 2021-06-01 | The Procter & Gamble Company | Absorbent structure |
US11173078B2 (en) | 2015-11-04 | 2021-11-16 | The Procter & Gamble Company | Absorbent structure |
US11376168B2 (en) | 2015-11-04 | 2022-07-05 | The Procter & Gamble Company | Absorbent article with absorbent structure having anisotropic rigidity |
US10729592B2 (en) | 2015-11-04 | 2020-08-04 | The Procter & Gamble Company | Absorbent structure |
US11266542B2 (en) | 2017-11-06 | 2022-03-08 | The Procter & Gamble Company | Absorbent article with conforming features |
US11857397B2 (en) | 2017-11-06 | 2024-01-02 | The Procter And Gamble Company | Absorbent article with conforming features |
US11864982B2 (en) | 2017-11-06 | 2024-01-09 | The Procter And Gamble Company | Absorbent article with conforming features |
US11890171B2 (en) | 2017-11-06 | 2024-02-06 | The Procter And Gamble Company | Absorbent article with conforming features |
Also Published As
Publication number | Publication date |
---|---|
FR2725625B1 (fr) | 1997-02-21 |
FR2725625A1 (fr) | 1996-04-19 |
EP0797458A1 (fr) | 1997-10-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2593852B2 (ja) | シリコーン成形組成物 | |
JP4365085B2 (ja) | ルテニウムメタセシス触媒を使用する歯科用印象材料 | |
TWI653279B (zh) | 可硬化多部分丙烯酸系組合物 | |
JP6076947B2 (ja) | 硬化性二部型アクリル系組成物及びその生成方法 | |
EP0797458A1 (fr) | Ciment osseux composite | |
EP3003414B1 (fr) | Implant a porosité controlée en un matériau hybride | |
FR2667309A1 (fr) | Composition de ciment hydraulique au phosphate de calcium et composition de ciment contenant un liquide de durcissement. | |
AU2003204330A1 (en) | Bone Cement Mixture and X-ray Contrast Medium As Well as Method for Their Preparation | |
CH680340A5 (fr) | ||
US20080293011A1 (en) | Tissue Conditioner for Dental Use | |
NL7907371A (nl) | Werkwijze voor het vervaardigen van een kunstmatige tandwortel, de aldus vervaardigde tandwortel en werk- wijze voor het aanbrengen hiervan. | |
CH668551A5 (fr) | Compositions pour ciment dentaire a l'aluminate. | |
EP0457660A1 (fr) | Nouveaux polymères absorbants, leur procédé de fabrication et leur application | |
WO1999037272A1 (fr) | Materiau de rebasage pour prothese, et son procede de production | |
EP0537053B1 (fr) | Nouveaux polymères absorbants, procédé de fabrication et leur application notamment aux articles d'hygiène | |
US5204414A (en) | Salts of polyalkyl vinyl ether maleic anhydride and dental prosthesis adhesive produced therefrom | |
FR2900332A1 (fr) | Composition dentaire en deux parties. | |
BE1010076A3 (fr) | Composition au silicone pour empreintes dentaires. | |
RU2689169C2 (ru) | Отверждаемые многосоставные акриловые композиции | |
BE1004223A4 (fr) | Composition dentaire pour la prise d'empreintes. | |
FR3088550A1 (fr) | Implant a porosite controlee en un materiau hybride dope en nutriment osteoinducteur | |
JPS587604B2 (ja) | ジンゾウイシヨクヘン オヨビ ソノセイゾウホウ | |
Ming Kuo et al. | Evaluating chitosan/β‐tricalcium phosphate/poly (methyl methacrylate) cement composites as bone‐repairing materials | |
JP2002541167A (ja) | 改良されたポリビニルシロキサン印象材 | |
Silvestri et al. | Molecularly imprinted bioartificial membranes for the selective recognition of biological molecules. Part 2: release of components and thermal analysis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 1995935505 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1995935505 Country of ref document: EP |
|
WWR | Wipo information: refused in national office |
Ref document number: 1995935505 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1995935505 Country of ref document: EP |